First Trust Advisors LP Vanda Pharmaceuticals Inc. Transaction History

First Trust Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $8,341 - $10,608	-896 Reduced 1.04%	84,967 $926,000
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $53,733 - $82,038	-4,957 Reduced 5.46%	85,863 $971,000
Q4 2021 Feb 08, 2022	BUY	$15.69 - $21.14 $165,137 - $222,498	10,525 Added 13.11%	90,820 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $1.23 Million - $1.71 Million	80,295 New	80,295 $1.38 Million
Q2 2019 Jul 30, 2019	SELL	$13.37 - $18.85 $1.72 Million - $2.42 Million	-128,598 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$17.59 - $31.05 $399,715 - $705,580	22,724 Added 21.46%	128,598 $2.37 Million
Q4 2018 Feb 07, 2019	BUY	$18.97 - $31.47 $2.01 Million - $3.33 Million	105,874 New	105,874 $2.77 Million
Q4 2017 Feb 08, 2018	SELL	$12.85 - $18.1 $898,754 - $1.27 Million	-69,942 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$15.4 - $18.85 $1.08 Million - $1.32 Million	69,942	69,942 $1.25 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.